number to the level of healthy individuals. Increased mortality and morbidity have been observed in these patients. In the current study, we have investigated the role of auto-IgGs in CD4 + T cell apoptosis and recovery in a cross-sectional study. All HIV + subjects were on viral- 
Introduction
The advent of ART has dramatically improved survival and disease progression in HIV-infected individuals [1] . ART treatment suppresses HIV viral replication, improves immune function, restores peripheral CD4 + T cell counts, and decreases morbidity and mortality [2] [3] [4] . However, long-term ART-treated patients exhibit an increased risk of cardiovascular diseases, cancer, osteoporosis, and other end-organ diseases [5] . Incomplete CD4 + T cell reconstitution is mainly accounting for these aging-like complications. The mechanisms of incomplete CD4 + T cell recovery in HIV disease have been studied extensively, including direct viral cytopathogenicity, lymphoid fibrosis and thymic insufficiency [6, 7] , indirect effects of persistent T cell activation and apoptosis [8] [9] [10] , gut mucosal dysfunction, and elevated levels of microbial translocation and inflammation [11, 12] . However, the exact mechanism is not fully understood.
In the current study, we examined the potential role of autoIgG binding on CD4 + T cell surfaces in HIV + subjects after longterm, viral-suppressive ART treatment. We found that CD4 + T cell apoptosis was elevated in HIV + subjects compared with healthy controls. The percentage of auto-IgG binding on CD4 + T cell surfaces was inversely correlated with CD4 + T cell counts in HIV + subjects. IgGs from plasma of HIV + subjects induced CD4 + T cell death through NK cytotoxicity (ADCC) in vitro. sCD4 protein preincubation prevented IgG-mediated CD4 + T cell death. Our results suggest that autoantibody-mediated CD4 + T cell death may reveal an important mechanism of incomplete immune recovery in virologically suppressed HIV disease.
MATERIALS AND METHODS

Study subjects
Sixteen healthy controls and 26 HIV + ART-treated, aviremic, HIV-infected subjects were evaluated in a cross-sectional study. The clinical characteristics are shown in Table 1 . All HIV + patients had been on ART treatment and had undetectable plasma HIV-1 RNA (,50 copies/ml) for at least 2 yr. The clinical characteristics of patients were shown in our previous study [13] . This study was approved by the Institutional Review Board from the Medical University of South Carolina.
Flow cytometry
The fluorochrome-labeled mAb used in this study included the following: antihuman CD3 (OKT3), anti-human CD4 (RPA-T4), anti-human CD8 (RPA-T8), anti-human CD27 (M-T271), anti-human CD45RA (HI100), annexin V (BD Pharmingen; BD Biosciences, San Jose, CA, USA), Ghost Dye Red 780 (Tonbo Biosciences, San Diego, CA, USA), and isotype control antibodies (BD Pharmingen; BD Biosciences). Cells were collected by a BD FACSVerse flow cytometer (BD Biosciences), and data were analyzed by FlowJo software (version 10.0.8; Ashland, OR, USA).
CD4 surface-bound IgG ex vivo
Plasma was isolated by centrifugation of EDTA-contained blood, aliquoted, and stored at 280°C. PBMCs were isolated over a Ficoll-Paque, and freshly isolated PBMCs were used for annexin V assays (see Fig. 1 ). Thawed PBMC samples were used for detecting surface-bound IgG on CD4 + T cells (see Fig. 2B and C). Fluorescent-labeled antibodies were incubated with PBMCs at 4°C for 30 min for surface staining, and the cells were washed and stained with annexin V and then analyzed by flow cytometry immediately.
CD4 surface-bound IgG detection using plasmas in vitro
PBMCs from a healthy control donor were cultured with PHA (2 mg/ml) at 37°C for 24 h, and plasma from HIV + subjects or healthy controls was inactivated at 56°C for 30 min. Then, PHA-stimulated PBMCs (5 3 10 5 cells)
were treated with 2.5 ml plasma in 50 ml buffer at 4°C for 60 min. After washing 33 with PBS, 50 ml aqua blue (Thermo Fisher Scientific, Waltham, MA, USA) was used at 4°C for 20 min to exclude dead cells. Next, 50 ml antibody cocktail containing anti CD3-PerCP (OKT3), CD4-BV421 (RPA-T4), CD8-PE-Cy7 (RPA-T8), CD27-APC-Cy7 (M-T271), CD45RA-FITC (HI100), IgM-APC (G20-127), and IgG-PE (G18-145) was surface stained at 4°C for 30 min. The cells were washed and analyzed by flow cytometry. 
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Statistical analysis
All data were analyzed and graphed using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, USA) and SPSS (Version 23; IBM, Armonk, NY, USA). Statistical significance between 2 groups was determined by the Mann-Whitney U test (nonparametric) and the ANOVA test (paired test) for 3 or more groups. Associations between pairs of continuous variables were analyzed by Spearman correlation tests.
RESULTS
CD4
+ T cells are highly apoptotic and depleted in viral-suppressed, ART-treated HIV + subjects ex vivo ) absolute counts were still not fully recovered, even after long-term ART treatment in some HIV + subjects compared with healthy control ( Fig. 1A and B ; P , 0.05). T Cell apoptosis is an important immunologic parameter for HIV disease progression [14] . In untreated HIV patients, T cells undergo apoptosis, leading to an eventual T cell decline [15] . In this study, we analyzed CD4 + T cell apoptosis using fresh blood samples. Consistent with the decline of CD4 + T cell counts, CD4 + T cells, including both nCD4 + and mCD4 + T cells from HIV + subjects, + T cells compared with IgG2CD4 + T cells (Fig. 2C) . HIV + subjects compared with healthy controls (Fig. 3A) . 1.84 in healthy controls and HIV + subjects separately; Fig. 3A and B).
NK cells purified from ART-treated HIV + subjects exhibit cytotoxicity to CD4 + T cells via surface-bound auto-IgGs
To analyze further the potential impact of surface autoantibodies on CD4
+ T cells, we purified NK cells and CD4 + T cells from ARTtreated, HIV-infected subjects that had high amounts of autoantibody on the CD4 + T cell surface (above 5 percentile; Fig. 3A ) or from healthy controls. Anti-CD4 IgGs (zanolimumab 6G5, a human mAb) served as the positive control. Surprisingly, coculture NK cells with autologous CD4 + T cells from HIV + subjects resulted in the increases of CD4 + T cell apoptosis and cytolysis compared with cells from healthy controls (Fig. 4A and B) .
To determine if the increased CD4 apoptosis is the result of greater proportions of auto-IgG antibodies, NK activation, or CD4 (Fig.  4E) . However, when autologous CD4 + T cells and NK cells from HIV + subjects were cultured with total IgG from high auto-IgG HIV + subjects, the induction of CD4 + T cell cytolysis was observed (Fig. 4E) . These results may suggest that NK activation, CD4 + T cell susceptibility, and concentration of autoantibodies are all important for the induction of CD4 + T cell death.
To determine the antibody-binding specificity that mediated CD4 + T cell death from HIV + subjects and whether this process is specific to CD4 + T cells, we assessed CD4 + T cell apoptosis and cytolysis after treatment with sCD4. Our results showed that the positive control anti-human mAb 6G5 mediated ADCC against CD4 + T cells, and sCD4 completely inhibited this effect ( Fig. 4F and  G) . Furthermore, coculture of autologous NK cells and CD4 + T cells from HIV + subjects resulted in NK-mediated CD4 + T cell death, and sCD4 significantly reduced this effect (Fig. 4F and G) . Unlike sCD4, sCD3 failed to protect the CD4 + T cells of HIV + subjects from death ( Fig. 4F and G) . These results implied that NK cell-mediated CD4 + T cell death in HIV disease is through CD4 binding.
DISCUSSION
In the current study, we found that elevated surface IgG binding on CD4 + T cells was inversely correlated with peripheral CD4 + T cell counts in aviremic, ART-treated subjects, and autoantibodies from plasma of HIV + subjects induced CD4 + T cell death through NK-mediated ADCC and CD4 surface binding. These results suggest a possible role of these antibodies in incomplete immune reconstitution in HIV disease. Previous studies in SIV and HIV have shown inverse correlations between plasma or serum autoantibody levels and peripheral CD4 + T cell counts, suggesting that autoantibodies against surface antigens on CD4 + T cells may play a role in CD4 + T cell decline [16] [17] [18] [19] . However, these studies only investigated autoantibodies of diverse surface proteins on CD4 + T cells in untreated HIV patients or animal models. In the current study, we show clear evidence that even after longterm, viral-suppressive ART treatment, autoantibodies that bind onto CD4 + T cell surfaces are not only present but also facilitate CD4 + T cell death by NK cell-mediated ADCC. The different results between previous studies and ours can be a result of different patient populations (ART-naïve patients in previous studies vs. aviremic, ART-treated patients in our study). Although autoimmune diseases may present in the stage of acute HIV infection, they mainly occur in the immunologic reconstitution phase after ART [20, 21] , suggesting that B cells may produce pathologic autoantibodies during immunologic recovery under ART.
The mechanism of NK cell-mediated ADCC against CD4 + T cells in vitro (Fig. 4E-G ) may be a result of auto-IgG-activated NK cytotoxicity against IgG + CD4 + T cells. In addition, the inhibition effect of sCD4 indicates CD4-specific binding. Therefore, the percentages of NK cell-induced CD4 + T cell death in vitro were low from HIV + subjects ( Fig. 4E-G ; interquartile ranges, 2-5%); however, the long-term effect of NK cells in CD4 + T cell recovery can be significant in vivo. Unlike HIV patients, healthy individuals have a low level of autoantibody bound to the surface of CD4 + T cells, but their cocultured NK cells did not induce cell death of autologous CD4 + T cells in vitro, suggesting a nonpathologic role of autoantibodies in plasma of healthy controls [22] . In addition, CD4 + T cells from HIV + subjects may be more susceptible to NK-mediated cytotoxicity compared with controls [23] . Consistently, our recent study showed that NK cells are activated in HIV patients with CD4 + T cell counts #350 cells/ml compared with healthy individuals and that the percentages of activated NK cells were inversely correlated with CD4 + T cell counts [24] . Notably, sCD4 but not sCD3 inhibited CD4 + T cell death induced by coculturing with autologous NK cells and autoantibodies, indicating a CD4-specific, autoantibody-mediated ADCC effect. However, whether other autoantibodies against surface antigens on CD4 + T cells also play a role in the ADCC needs to be explored further.
The source of the autoantibodies against CD4 + T cells still needs to be addressed. Notably, in recent studies found in lymph nodes and tissues, HIV still actively replicates, even in patients with complete viral suppression under ART [25] . As a consequence, HIV may lead to CD4 + T cell death directly or indirectly. At the same time, the lower frequencies of macrophages and impaired macrophage function in HIV-infected subjects [26] failed to clear the apoptotic debris and immune complexes [27, 28] , which may result in an increased level of self-antigens. + T cell apoptosis (F) or CD4 + T cells cytolysis (G) from HIV + subjects cultured with autologous NK cells, with or without sCD4 (25 mg/ml), sCD3 (25 mg/ml), and zanolimumab-6G5 antibody (5 mg/ml) in vitro. ANOVA, paired.
